Recombinant Human F13A (C-6His)

Catalog Number: EKL-PHH0612
Article Name: Recombinant Human F13A (C-6His)
Biozol Catalog Number: EKL-PHH0612
Supplier Catalog Number: PHH0612
Alternative Catalog Number: EKL-PHH0612-10UG,EKL-PHH0612-50UG,EKL-PHH0612-500UG
Manufacturer: EnkiLife
Host: Human
Category: Proteine/Peptide
Species Reactivity: Human
Alternative Names: Coagulation Factor XIII A Chain, Coagulation Factor XIIIa, Protein-Glutamine Gamma-Glutamyltransferase A Chain, Transglutaminase A Chain, F13A1, F13A
Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.
Molecular Weight: 80.3 KDa
NCBI: 27963
Purity: Greater than 95% as determined by reducing SDS-PAGE